Unusual hyperthermia related to general anaesthesia in an Anatolian shepherd dog

https://doi.org/10.17221/123/2017-VETMEDCitation:Guzel O, Yildar E, Karan B, Aydin D, Mckinstry DS (2018): Unusual hyperthermia related to general anaesthesia in an Anatolian shepherd dog. Veterinarni Medicina, 63: 36-39.
download PDF

This case report describes the diagnosis, the treatment options available in the absence of dantrolene and outcome of anaesthesia-related hyperthermia seen for the first time in an Anatolian shepherd dog. The case consisted of a nine-month-old male Anatolian shepherd dog with bilateral antebrachium fractures. For surgical treatment, the patient was pre-medicated with xylazine; anaesthesia was induced using ketamine and maintained with isoflurane. Approximately 40 minutes after isoflurane administration, tachypnoea, tachycardia, increase in body temperature and rigidity in the forelegs and masseter muscles was noticed. Inhalation anaesthesia was discontinued and hyperventilation was performed with 100% O2. Due to its vasodilatory properties, diazepam was administered both to achieve muscle relaxation and to decrease body temperature. Alfentanil was used in an attempt to lower respiratory and heart rates. Intravenous administration of cold crystalloid solutions and external ice packs was used to lower body temperature. All these interventions kept the patient alive.

References:
Adami Chiara, Axiak Shannon, Raith Karina, Spadavecchia Claudia (2012): Unusual perianesthetic malignant hyperthermia in a dog. Journal of the American Veterinary Medical Association, 240, 450-453 https://doi.org/10.2460/javma.240.4.450
 
Antognini JF (1995): Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures. Anesthesia and Analgesia 81, 1039–1042.
 
Barhoumi Rola, Burghardt Robert C., Qian Yongchang, Tiffany-Castiglioni Evelyn (2007): Effects of propofol on intracellular Ca2+ homeostasis in human astrocytoma cells. Brain Research, 1145, 11-18 https://doi.org/10.1016/j.brainres.2007.01.118
 
Brunson David B., Hogan Kirk J. (2004): Malignant hyperthermia: a syndrome not a disease. Veterinary Clinics of North America: Small Animal Practice, 34, 1419-1433 https://doi.org/10.1016/j.cvsm.2004.05.010
 
Chohan Amandeep S., Greene Stephen A. (2011): Anesthesia Case of the Month. Journal of the American Veterinary Medical Association, 239, 936-940 https://doi.org/10.2460/javma.239.7.936
 
Fruen Bradley R., Mickelson James R., Roghair Timothy J., Litterer Lynn A., Louis Charles F. (1995): Effects of Propofol on Calcium sup 2+ Regulation by Malignant Hyperthermia-susceptible Muscle Membranes. Anesthesiology, 82, 1274-1282 https://doi.org/10.1097/00000542-199505000-00023
 
Gronert GA, Milde JH (1981): Variations in onset of porcine malignant hyperthermia. Anesthesia and Analgesia 60, 499–503.
 
Kahraman NK, Kantarci G, Kahraman C (2009): Case report of an acute uremia secondary to rhabdomyolysis and hypovolemia. Turkish Nephrology, Dialysis and Transplantation Journal 18, 90–93.
 
Kirmayer AH, Klide AM, Purvance JE (1984): Malignant hyperthermia in a dog – Case report and review of the syndrome. JAVMA-Journal of the American Veterinary Medical Association 185, 978–982.
 
Krause T., Gerbershagen M. U., Fiege M., Weißhorn R., Wappler F. (2004): Dantrolene ? A review of its pharmacology, therapeutic use and new developments. Anaesthesia, 59, 364-373 https://doi.org/10.1111/j.1365-2044.2004.03658.x
 
Lamont LA, Mathews KA (2007): Opioids, nonsteroidal anti-inflammatories, and analgesic adjuvants. In: Tranquilli WJ, Thurmon JC, Grimm KA (eds): Lumb and Jones’ Veterinary Anesthesia and Analgesia. 4th edn. Blackwell Publishing, Iowa. 241–271.
 
Lemke KA (2007): Anticholinergics and sedatives. In: Tranquilli WJ, Thurmon JC, Grimm KA (eds): Lumb and Jones’ Veterinary Anesthesia and Analgesia. 4th edn. Blackwell Publishing, Iowa. 203–239.
 
Migita T., Mukaida K., Kawamoto M., Kobayashi M., Yuge O. (2007): Propofol-induced changes of myoplasmic calcium concentration in cultured human skeletal muscles from RYR1 mutation carriers. European Journal of Anaesthesiology, 24, 120- https://doi.org/10.1097/00003643-200706001-00447
 
Murao K, Umegaki T, Masuzawa M, Masuzawa M, Inoue S, Nakao S, Shingu K (2010): Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH. The Japanese Journal of Anesthesiology 59, 92–96.
 
Nelson TE (1991): Malignant hyperthermia in dogs. Journal of the American Veterinary Medical Association 198, 989–994.
 
O’Brien PJ, Cribb PH, White RJ, Olfert ED, Steiss JE (1983): Canine malignant hyperthermia – Diagnosis of susceptibility in a breeding colony. Canadian Veterinary Journal 24, 172–177.
 
Roberts Monica C., Mickelson James R., Patterson Edward E., Nelson Thomas E., Jane Armstrong P., Brunson David B., Hogan Kirk (2001): Autosomal Dominant Canine Malignant Hyperthermia Is Caused by a Mutation in the Gene Encoding the Skeletal Muscle Calcium Release Channel (RYR1). Anesthesiology, 95, 716-725 https://doi.org/10.1097/00000542-200109000-00026
 
download PDF

© 2018 Czech Academy of Agricultural Sciences